Intraperitoneal Aerosolized Delivery of a Local Anesthetic for Post Operative Pain Management. A Double Blind, Randomised Controlled Clinical Trial.

Status unconfirmed · Not applicable

Conditions studied: Pain, Postoperative, Postoperative Pain, Abdominal Pain, Obesity, Pneumoperitoneum

In brief

The purpose of this study is to determine the effectiveness of aerosolized pain medication (.5% bupivicaine) delivered into the peritoneal cavity after laparoscopic gastric bypass surgery. This double blind study will include 50 patients. 25 will receive the aerosolized pain medication and 25 will receive a placebo (normal saline). All 50 patients will receive routine/typical methods of post-operative pain management. Post operative pain scores of the patients will be examined to determine the effect of aerosolization.

Key facts

Study ID

NCT00286286

Run by

Northgate Technologies

People needed

50

Starts

2006-02-01

Expected to finish

2006-08-01

Last updated by the study team

2007-01-11

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female patients between the ages of 18-65
• Patients in general good health requiring elective surgery

You may not qualify if…

• Female patients that are pregnant
• Patients allergic to bupivicaine
• Patients who have used narcotic drugs within 30 days of the surgical procedure.

Where it is running

• Alexian Brothers Medical Center — Elk Grove Village, Illinois, United States
• St. Alexius Medical Center — Hoffman Estates, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.